Skip to main content
ACOG
NASDAQ Life Sciences

10% Owner Opaleye Management Buys Over $1 Million in Alpha Cognition Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$6.01
Mkt Cap
$130.67M
52W Low
$3.75
52W High
$11.54
52W Position info
60% above low
Off High info
48% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

ACOG sits 60% above its 52-week low of $3.75.

Summary

Opaleye Management Inc., a 10% owner of Alpha Cognition Inc., significantly increased its stake by purchasing over $1 million worth of common stock in open market transactions.


Key Events · Ownership and Investor Activity · ACOG

  • Significant Insider Purchase

    Opaleye Management Inc., a 10% owner, acquired 171,410 shares of Alpha Cognition Inc. common stock for a total of $1,003,958 through open market purchases.

  • Increased Stake

    These transactions, occurring between February 20 and February 24, 2026, demonstrate a notable increase in the investment firm's position in the company.


Analysis · ACOG · Life Sciences

Opaleye Management Inc., a significant 10% owner, has made a substantial open market purchase of Alpha Cognition Inc. shares. This $1 million investment, executed over several days, signals strong conviction from a major institutional investor. Such a notable increase in stake by a large shareholder can be interpreted as a positive vote of confidence in the company's future prospects, potentially influencing other investors.

How filings like this one have moved

In the 30 days to Sep 18, 2026, 29.2% of the 1722 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ACOG was trading at $6.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $130.7M. The 52-week trading range was $3.75 to $11.54. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ACOG - Latest Insights

ACOG
Sep 16, 2026, 5:57 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $8.47
Real-time Price: $8.85 info
Change: +$0.380 (+4%) info
Market Cap: $192.734M info
ACOG
Aug 13, 2026, 4:48 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.65
Real-time Price: $8.85 info
Change: -$0.800 (-8%) info
Market Cap: $192.734M info
ACOG
Jul 29, 2026, 8:30 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $8.75
Real-time Price: $8.85 info
Change: +$0.100 (+1%) info
Market Cap: $192.734M info
ACOG
Jul 24, 2026, 4:05 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $7.90
Real-time Price: $8.85 info
Change: +$0.950 (+12%) info
Market Cap: $192.734M info
ACOG
Jun 29, 2026, 4:05 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $6.81
Real-time Price: $8.85 info
Change: +$2.04 (+30%) info
Market Cap: $192.734M info